SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?


To: i-node who wrote (756252)1/30/2022 3:25:16 PM
From: skinowski5 Recommendations

Recommended By
Bruce L
frankw1900
garrettjax
i-node
pheilman_

  Read Replies (1) | Respond to of 793928
 
Having a sequenced virus, it’s not difficult to design a messenger RNA needed to create antibodies against a targeted protein in the virus. The work is in testing - and getting approvals - and then manufacturing and distributing.

But, this virus keeps changing. It worked well against the original CoViD - but not so much against Delta. Supposedly, it makes the disease milder. Ditto re Omicron.

They are working on a Omicron vaccine, apparently it will be around by March. One little problem - by March, omicron will be more or less gone. It’s burning through communities like wildfire, and the cases are already in a sharp decline. Not to mention that omicron is mild and it’s not clear whether it even warrants special vaccination.

So, our fearless vaccinators are in a spot of trouble. If it weren’t for the government obstinance, there would be hardly any market for their product (which is literally outdated last year’s vaccines).

Imo, they will soon realize they need to do the same thing they’ve been doing with flu - for decades. Check all over the world for emerging new strains, estimate the odds for a particular strain to reach out shores - and start making vaccines pro-actively, without waiting to have millions of cases in the US.

Hopefully, new strains will be even milder - and the issue will be gone.